Institutional investors purchased a net $18.1 million shares of GSK during the quarter ended June 2015 and now own 9.69% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NLB SKLADI, D.O.O. Bought 4.1 Thousand shares of GlaxoSmithKline
REDWOOD ASSET MANAGEMENT, INC. Bought 82.00 shares of GlaxoSmithKline